Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06610058 · ClinicalTrials.gov registry record · NA

Effects of Instrument Assisted Soft Tissue Mobilization Regarding Range of Motion and Lower Extremity Power

A NA study of Healthy, sponsored by Beth Marschner.

Completed
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT06610058: Completed NA study of Healthy, sponsored by Beth Marschner.

NCT06610058 is a NA study of Healthy that has completed, run by Beth Marschner. The registered enrollment target is 50 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06610058, a NA study of Healthy, has completed, sponsored by Beth Marschner.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to study the effects of instrument assisted soft tissue mobilization (IASTM) in healthy adult volunteers. The main questions it aims to answer are: * Does IASTM treatment have an effect on range of motion (ROM) as measured in the hip, knee and ankle? * Does IASTM treatment have an effect on lower extremity power? Researchers will compare pre-test and post-test IASTM treatment intervention data to the pre-test and post-test data of the no treatment control intervention to see if IASTM works to change range of motion and/or lower extremity power. Participants will: * Complete a questionnaire on medical history and injury background * Have hip, knee and ankle range of motion (ROM) measurements taken on both lower extremities using a goniometer * Complete three trials of vertical jump testing using a Fleage Floor standing vertical jump measurement tester with one warm up first * Complete three trials of horizontal jump testing using a Woanger 12'x2.5' long jump mat and verified by a secondary measure using a tape measure with one warm up first * Be randomly assigned to either IASTM first treatment group or the wait/control first group * Receive IASTM treatment techniques including application of emollient to the skin to reduce friction on the surface followed by scanning the hamstrings, quadriceps, gastroc/soleus complex, and Achilles tendon using the HG8-Scanner tool for 15 strokes in each direction. Then the concave tool corresponding to the size of the structure being treated will be used (HG6-Large Multi-Curve, HG5-Medium Multi-Curve, HG4-Small Multi-Curve) for 15 strokes in each direction. * Simply wait for 20 minutes (the duration of time treatment with IASTM would require) when completing the control treatment. * Complete hip, knee and ankle range of motion and vertical and horizontal jump measure testing at the end of the first session. * Return within fourteen days after the first session in order to undergo the opposite ex

Conditions Studied

Interventions

  • OTHER Instrument Assisted Soft Tissue Mobilization first Control second
  • OTHER Control first Instrument Assisted Soft Tissue Mobilization second

Study Locations (1)

North Dakota

  • Minot State University - Minot

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2024-01-08
Est. Completion 2024-02-29
Phase NA

Sponsor

Beth Marschner

4 total trials

What the Registry Record Tells You About NCT06610058

The ClinicalTrials.gov registry entry for NCT06610058 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (92% lower). The listed sponsor is Beth Marschner, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which Instrument Assisted Soft Tissue Mobilization first Control second is the first listed.

NCT06610058 reports 1 study location spanning 1 distinct geographic area - top geographies include North Dakota.

Frequently Asked Questions

What is clinical trial NCT06610058 about?

NCT06610058 is a clinical study titled "Effects of Instrument Assisted Soft Tissue Mobilization Regarding Range of Motion and Lower Extremity Power". The goal of this clinical trial is to study the effects of instrument assisted soft tissue mobilization (IASTM) in healthy adult volunteers. The main questions it aims to answer are: * Does IASTM treatment have an effect on range of motion (ROM) as measured in the hip, knee and ankle? * Does IASTM ...

What is the current status of trial NCT06610058?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2024-01-08. Estimated completion is 2024-02-29.

What conditions does trial NCT06610058 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT06610058?

The interventions under investigation include: Instrument Assisted Soft Tissue Mobilization first Control second (OTHER), Control first Instrument Assisted Soft Tissue Mobilization second (OTHER).

Who is sponsoring clinical trial NCT06610058?

This trial is sponsored by Beth Marschner, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06610058 being conducted?

This trial has 1 study location across North Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.